KIMBERLEY PHILIP: Open Payments
NPI 1538130919 · LARGO, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,216 in 100 payments from 28 companies in 2025. Trend: 2023 $2,784 · 2024 $2,306 · 2025 $2,216
Food & beverage: $2,216
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 22 | $296 |
| Dexcom, Inc. | 10 | $293 |
| Novartis Pharmaceuticals Corporation | 8 | $220 |
| Amgen Inc. | 4 | $193 |
| Bayer Healthcare Pharmaceuticals Inc. | 11 | $160 |
| SANOFI-AVENTIS U.S. LLC | 4 | $105 |
| Antares Pharma, Inc. | 5 | $103 |
| Lilly USA, LLC | 3 | $72 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $72 |
| Insulet Corporation | 3 | $68 |
Products named: Dexcom G6 Transmitter, LEQVIO, Kerendia, EVENITY, Ozempic, Rybelsus, TZIELD, XYOSTED.
Industry payments across FL — which companies pay providers there.
